Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
about
Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammationCytokines in psoriasisInflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermisNovel production of interleukin-1 receptor antagonist peptides in normal human cornea.Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surfaceEffects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes.Interleukin-1 polymorphisms and graft-vs-host disease.Impaired Langerhans cell migration in psoriasis.Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cellsInflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin diseaseDanger signals activating the immune response after trauma.Mast cells in psoriatic skin are strongly positive for interferon-gamma.The interleukin-1 type 2 receptor gene displays immediate early gene responsiveness in glucocorticoid-stimulated human epidermal keratinocytes.Keratinocytes and cytokine/growth factors.Opposing effects of ultraviolet B irradiation on interleukin-1 receptor antagonist and interleukin-1 alpha messenger RNA expression in a human epidermoid carcinoma cell line.Preferential production of interleukin-1 beta over interleukin-1 receptor antagonist contributes to proliferation and suppression of apoptosis in leukemic cells.Is the inflammasome a potential therapeutic target in renal disease?Expression of interleukin (IL)-1 family members upon stimulation with IL-17 differs in keratinocytes derived from patients with psoriasis and healthy donors.Skin-infiltrating lymphocytes in normal and disordered skin: activation signals and functional roles in psoriasis and mycosis fungoides-type cutaneous T cell lymphoma.Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.Expression and regulation of alarmin cytokine IL-1α in human retinal pigment epithelial cells.
P2860
Q24673428-CE6A287B-F43A-46E9-A5DA-9014ACFB0478Q28255491-C60B4534-175A-42C6-8D79-8722580BC432Q33730207-2102202E-ADB9-4FAA-A34B-CB49C6BC8F3AQ34192949-F00A7E26-5345-436F-B0EE-D68960252B8AQ34236293-F7C91A60-679B-4B84-9121-C303E7C19717Q35185468-C937CD55-3D96-45D7-8449-F18660B44BC1Q35552826-701FF842-A6A2-4F7E-BF2F-44C3A40E8E79Q36194613-4638C3C0-5DF1-4EBA-A1B4-1C1F97947482Q36228584-10EBF2AD-3F4D-4995-8F40-2A7F0398C355Q37179132-8136D913-93BC-4774-BF35-4955D1C7BDA7Q37357518-102B5B69-BA00-4EB0-838C-F2733A7AB6B5Q38025082-57FDBFA6-D36F-4181-9A33-49694A1430AAQ40955777-59BC09F9-046E-4C90-8751-593C244DBBDDQ40966203-DDC5716F-3E03-46EE-A594-42E7261727A2Q41294970-6E84DB90-C16E-4E01-BF16-8DD1C6E60B9BQ41336894-6E07162A-62A6-4F5E-B40C-C82C3B9E2B64Q41376911-CE8DE6BB-3142-4FA7-8FD8-4B15DD1F5C9EQ41934684-D40D8E04-5AAF-4690-AC4F-78654948C5FAQ42485343-C986A49F-9DBF-473A-92E0-415BC6B30F65Q45501663-27C4F00F-9374-452F-BF99-4C11251751D4Q47912627-CE023C93-BF53-48A9-AD87-EE05C5937A1BQ49276761-3313BB68-1BE6-4771-B717-91140B1C0E6DQ52351407-AB00CF3C-2403-4456-B083-EAC6A2EFAF99
P2860
Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
@ast
Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
@en
type
label
Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
@ast
Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
@en
prefLabel
Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
@ast
Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
@en
P2093
P2860
P356
P1476
Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
@en
P2093
A E Berger
C Hammerberg
G J Fisher
J J Voorhees
J S Haskill
K D Cooper
P2860
P304
P356
10.1172/JCI115896
P407
P577
1992-08-01T00:00:00Z